PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (ANTI-AGING)
DRUG NAME: MOTS-C
FDA Safety Data Sheet not available (experimental peptide).
Zheng Y. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023 [PubMed Link]
Kal S. Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives. Peptides. 2024 [PubMed Link]
Zhou Q. The correlation between mitochondrial derived peptide (MDP) and metabolic states: a systematic review and meta-analysis. Diabetol Metab Syndr. 2024 [PubMed Link]
Kong BS. Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases. Diabetes Metab J. 2023 [PubMed Link]
Mohtashami Z. MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. Int J Mol Sci. 2022 [PubMed Link]
Rochette L. Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction. Arch Cardiovasc Dis. 2022 [PubMed Link]
Wan W. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. J Transl Med. 2023 [PubMed Link]
Gao Y. MOTS-c Functionally Prevents Metabolic Disorders. Metabolites. 2023 [PubMed Link]
Yi X. Role of MOTS-c in the regulation of bone metabolism. Front Physiol. 2023 [PubMed Link]
Miller B. Mitochondria-derived peptides in aging and healthspan. J Clin Invest. 2022 [PubMed Link]
Woodhead JST. Mitochondrial-derived peptides and exercise. Biochim Biophys Acta Gen Subj. 2021 [PubMed Link]
Merry TL. Mitochondrial-derived peptides in energy metabolism. Am J Physiol Endocrinol Metab. 2020 [PubMed Link]
Wu Y. Mitochondrial-Derived Peptides in Diabetes and Its Complications. Front Endocrinol (Lausanne). 2022 [PubMed Link]
Kim SJ. Mitochondrial-derived peptides in aging and age-related diseases. Geroscience. 2021 [PubMed Link]
Dabravolski SA. The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets. Int J Mol Sci. 2021 [PubMed Link]